Syncom Formulations India Ltd approves Q2 FY27 results, reporting consolidated revenue of ₹142.14 crore and net profit of ₹26.65 crore
- Consolidated revenue rose 16.8% year on year; net profit increased 60.5% to ₹26.65 crore, with an estimated operating margin of 21.4%.
- Standalone revenue was ₹136.66 crore and net profit ₹25.40 crore, up 12.5% and 50.8% year on year, respectively.
- No exceptional items were reported; auditors’ limited reviews noted no material misstatement or non-compliance.
